Interestingly, many of the biological pathways that have emerged as influential in discriminative gene sets, such as hormone receptor activation and cellular proliferation (van't Veer et al, 2002; Gruvberger et al, 2003), have long been known to be important in distinguishing different types of breast cancer and are routinely assessed. The gene discussed is NR4A1; the disease is breast carcinoma.